drugset / Trial / NCT03629418

Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery

NCT03629418

Recruiting 612 enrolled Peking University First Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.

Timeline

Start
2018-08-14
Primary completion
2025-12
Completion
2026-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified
Subject Phenylephrine Small molecule 25 ug
Subject Phenylephrine Small molecule 50 ug

Indications